Therefore, re-establishing Wnt signaling could be a possible approach to treat AD since it could prevent synaptic loss, decrease Aβ synthesis, block tau phosphorylation, and control neuroinflammation [64]. The gene discussed is MAPT; the disease is Alzheimer disease.